Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 : Market Research Report

Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Published: Sep. 30, 2008 - 141 Pages

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?; 2.2 Definitions
3 Healthcare Sector Review: 3.1 Healthcare Sector Review; 3.2 Healthcare Expenditure; 3.3 Healthcare Infrastructure; 3.4 Healthcare Policy
4 Drug Delivery Devices in Belgium: 4.1 Drug Delivery Devices Overall Revenues (2000-2012); 4.2 Drug Delivery Devices Overall Volume (2000-2012); 4.3 Drug Delivery Devices Company Shares (2005-2006)
5 Inhalation Systems in Belgium: 5.1 Inhalation Systems Overall Revenues (2000-2012); 5.2 Inhalation Systems Overall Volume (2000-2012); 5.3 Inhalation Systems Average Price (2000-2012); 5.4 Inhalation Systems Distribution Share (2005-2006); 5.5 Inhalation Systems Company Share (2005-2006)
6 Infusion Systems in Belgium: 6.1 Infusion Systems Overall Revenues (2000-2012); 6.2 Infusion Systems Overall Volume (2000-2012); 6.3 Infusion Systems Average Price (2000-2012); 6.4 Infusion Systems Distribution Share (2005-2006); 6.5 Infusion Systems Company Share (2005-2006)
7 AstraZeneca PLC Company Profile: 7.1 Company Overview; 7.2 Business Overview; 7.3 Locations And Subsidiaries
8 3M Company Profile: 8.1 Company Overview; 8.2 Business Overview; 8.3 Value Chain Analysis; 8.4 SWOT Analysis; 8.5 Financial and Operational Review; 8.6 Locations And Subsidiaries; 8.7 Other Locations & Subsidiaries
9 GlaxoSmithKline plc Company Profile: 9.1 Company Overview; 9.2 Business Overview; 9.3 Locations And Subsidiaries; 9.4 Other Locations & Subsidiaries
10 Baxter International Company Profile: 10.1 Company Overview; 10.2 Business Overview; 10.3 Value Chain Analysis; 10.4 SWOT Analysis; 10.5 Financial and Operational Review; 10.6 Locations And Subsidiaries; 10.7 Other Locations & Subsidiaries; 10.8 Baxter International Inc. Pipeline Products
11 Novartis AG Company Profile: 11.1 Company Overview; 11.2 Business Overview; 11.3 Locations And Subsidiaries; 11.4 Other Locations & Subsidiaries
12 Regulation System: 12.1 Medical Equipment Approval Process; 12.2 Notification Fee
13 Pricing and Reimbursement: 13.1 Reimbursement Policies
14 Distribution Structure
15 Appendix: 15.1 Global Markets Direct Research Methodology; 15.2 Coverage; 15.3 Secondary Research; 15.4 Primary Research; 15.5 Models; 15.6 Forecasts; 15.7 Expert Panels; 15.8 Currency Conversion; 15.9 Contact Us; 15.10 Disclaimer
1.1 List of Tables: Table 1: Hospitals and Hospital Beds in Belgium, 2005; Table 2: Number of Doctors by Specialty in Belgium, 2003-2007; Table 3: Number of Hospital Wards by Specialty in Belgium, 2003-2007; Table 4: Drug Delivery Devices, Belgium, Overall Revenues ($ mn), 2000-2012; Table 5: Drug Delivery Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 6: Drug Delivery Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 7: Drug Delivery Devices, Belgium, Category Revenues ($ mn), 2000-2012; Table 8: Drug Delivery Devices, Belgium, Category Revenues ($ mn), Historic, 2000-2007; Table 9: Drug Delivery Devices, Belgium, Category Revenues ($ mn), Forecast, 2007-2012; Table 10: Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2012; Table 11: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2000-2007; Table 12: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2007-2012; Table 13: Drug Delivery Devices, Belgium, Company Share by Revenue ($ mn), 2005-2006; Table 14: Inhalation Systems, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 15: Inhalation Systems, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 16: Inhalation Systems, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007; Table 17: Inhalation Systems, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012; Table 18: Metered Dose Inhaler Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 19: Metered Dose Inhaler Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 20: Dry Powder Inhaler Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 21: Dry Powder Inhaler Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 22: Inhalation Systems, Belgium, Overall Volume (Units), Historic, 2000-2007; Table 23: Inhalation Systems, Belgium, Overall Volume (Units), Forecast, 2007-2012; Table 24: Metered Dose Inhaler Devices, Belgium, Overall Volume (Units), Historic, 2000-2007; Table 25: Metered Dose Inhaler Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012; Table 26: Dry Powder Inhaler Devices, Belgium, Overall Volume (Units), Historic, 2000-2007; Table 27: Dry Powder Inhaler Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012; Table 28: Metered Dose Inhaler Devices, Belgium, Average Price ($), Historic, 2000-2007; Table 29: Metered Dose Inhaler Devices, Belgium, Average Price ($), Forecast, 2007-2012; Table 30: Dry Powder Inhaler Devices, Belgium, Average Price ($), Historic, 2000-2007; Table 31: Dry Powder Inhaler Devices, Belgium, Average Price ($), Forecast, 2007-2012; Table 32: Inhalation Systems, Belgium, Distribution Share by Revenue ($ mn), 2005-2006; Table 33: Inhalation Systems, Belgium, Company Share by Revenue ($ mn), 2005-2006; Table 34: Infusion Systems, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 35: Infusion Systems, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 36: Infusion Systems, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007; Table 37: Infusion Systems, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012; Table 38: Infusion Disposable Sets, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 39: Infusion Disposable Sets, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 40: Syringe Pumps, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 41: Syringe Pumps, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 42: Infusion Pumps, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Table 43: Infusion Pumps, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Table 44: Infusion Systems, Belgium, Overall Volume (Units), Historic, 2000-2007; Table 45: Infusion Systems, Belgium, Overall Volume (Units), Forecast, 2007-2012; Table 46: Infusion Disposable Sets, Belgium, Overall Volume (Units), Historic, 2000-2007; Table 47: Infusion Disposable Sets, Belgium, Overall Volume (Units), Forecast, 2007-2012; Table 48: Syringe Pumps, Belgium, Overall Volume (Units), Historic, 2000-2007; Table 49: Syringe Pumps, Belgium, Overall Volume (Units), Forecast, 2007-2012; Table 50: Infusion Pumps, Belgium, Overall Volume (Units), Historic, 2000-2007; Table 51: Infusion Pumps, Belgium, Overall Volume (Units), Forecast, 2007-2012; Table 52: Infusion Pumps, Belgium, Average Price ($), Historic, 2000-2007; Table 53: Infusion Pumps, Belgium, Average Price ($), Forecast, 2007-2012; Table 54: Syringe Pumps, Belgium, Average Price ($), Historic, 2000-2007; Table 55: Syringe Pumps, Belgium, Average Price ($), Forecast, 2007-2012; Table 56: Infusion Disposable Sets, Belgium, Average Price ($), Historic, 2000-2007; Table 57: Infusion Disposable Sets, Belgium, Average Price ($), Forecast, 2007-2012; Table 58: Infusion Systems, Belgium, Distribution Share by Revenue ($ mn), 2005-2006; Table 59: Infusion Systems, Belgium, Company Share by Revenue ($ mn), 2005-2006; Table 60: AstraZeneca PLC, Subsidiaries; Table 61: 3M Company, SWOT Analysis, 2006; Table 62: 3M Company, Financial Statements, USD Million, 2002-2006; Table 63: 3M Company, Financial and Operational Overview, USD Million, 2002-2006; Table 64: 3M Company, Subsidiaries; Table 65: GlaxoSmithKline plc, Subsidiaries; Table 66: Baxter International Inc., SWOT Analysis, 2006; Table 67: Baxter International Inc., Financial Statements, USD Million, 2002-2006; Table 68: Baxter International Inc., Financial Ratios, USD Million, 2002-2006; Table 69: Baxter International Inc., Other Locations; Table 70: Baxter International Inc., Subsidiaries; Table 71: Novartis Medical Nutrition, Other Locations; Table 72: Medical Equipment Notification Fee in Belgium, 2007; Table 73: Currency Conversion from USD to Local Currency at 2007 Constant Rate 1
1.2 List of Figures: Figure 1: Total Healthcare Expenditure in Belgium, 2000 - 2006; Figure 2: Structure of Healthcare System in Belgium, 2007; Figure 3: Drug Delivery Devices, Belgium, Overall Revenues ($ mn), 2000-2012; Figure 4: Drug Delivery Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 5: Drug Delivery Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 6: Drug Delivery Devices, Belgium, Category Revenues ($ mn), 2000-2012; Figure 7: Drug Delivery Devices, Belgium, Category Revenues ($ mn), Historic, 2000-2007; Figure 8: Drug Delivery Devices, Belgium, Category Revenues ($ mn), Forecast, 2007-2012; Figure 9: Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2012; Figure 10: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2000-2007; Figure 11: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2007-2012; Figure 12: Drug Delivery Devices, Belgium, Company Share (%), 2006; Figure 13: Inhalation Systems, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 14: Inhalation Systems, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 15: Inhalation Systems, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007; Figure 16: Inhalation Systems, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012; Figure 17: Metered Dose Inhaler Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 18: Metered Dose Inhaler Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 19: Dry Powder Inhaler Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 20: Dry Powder Inhaler Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 21: Inhalation Systems, Belgium, Overall Volume (Units), Historic, 2000-2007; Figure 22: Inhalation Systems, Belgium, Overall Volume (Units), Forecast, 2007-2012; Figure 23: Metered Dose Inhaler Devices, Belgium, Overall Volume (Units), Historic, 2000-2007; Figure 24: Metered Dose Inhaler Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012; Figure 25: Dry Powder Inhaler Devices, Belgium, Overall Volume (Units), Historic, 2000-2007; Figure 26: Dry Powder Inhaler Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012; Figure 27: Metered Dose Inhaler Devices, Belgium, Average Price ($), Historic, 2000-2007; Figure 28: Metered Dose Inhaler Devices, Belgium, Average Price ($), Forecast, 2007-2012; Figure 29: Dry Powder Inhaler Devices, Belgium, Average Price ($), Historic, 2000-2007; Figure 30: Dry Powder Inhaler Devices, Belgium, Average Price ($), Forecast, 2007-2012; Figure 31: Inhalation Systems, Belgium, Distribution Share (%), 2006; Figure 32: Inhalation Systems, Belgium, Company Share (%), 2006; Figure 33: Infusion Systems, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 34: Infusion Systems, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 35: Infusion Systems, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007; Figure 36: Infusion Systems, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012; Figure 37: Infusion Disposable Sets, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 38: Infusion Disposable Sets, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 39: Syringe Pumps, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 40: Syringe Pumps, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 41: Infusion Pumps, Belgium, Overall Revenues ($ mn), Historic, 2000-2007; Figure 42: Infusion Pumps, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 43: Infusion Disposable Sets, Belgium, Overall Volume (Units), Historic, 2000-2007; Figure 44: Infusion Disposable Sets, Belgium, Overall Volume (Units), Forecast, 2007-2012; Figure 45: Syringe Pumps, Belgium, Overall Volume (Units), Historic, 2000-2007; Figure 46: Syringe Pumps, Belgium, Overall Volume (Units), Forecast, 2007-2012; Figure 47: Infusion Pumps, Belgium, Overall Volume (Units), Historic, 2000-2007; Figure 48: Infusion Pumps, Belgium, Overall Volume (Units), Forecast, 2007-2012; Figure 49: Infusion Pumps, Belgium, Average Price ($), Historic, 2000-2007; Figure 50: Infusion Pumps, Belgium, Average Price ($), Forecast, 2007-2012; Figure 51: Syringe Pumps, Belgium, Average Price ($), Historic, 2000-2007; Figure 52: Syringe Pumps, Belgium, Average Price ($), Forecast, 2007-2012; Figure 53: Infusion Disposable Sets, Belgium, Average Price ($), Historic, 2000-2007; Figure 54: Infusion Disposable Sets, Belgium, Average Price ($), Forecast, 2007-2012; Figure 55: Infusion Systems, Belgium, Distribution Share (%), 2006; Figure 56: Infusion Systems, Belgium, Company Share (%), 2006; Figure 57: 3M Company, Value Chain Analysis; Figure 58: Baxter International Inc., Value Chain Analysis; Figure 59: Flowchart for Classification of Non-invasive Devices in Belgium, 2007; Figure 60: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 61: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 62: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 63: Flowchart for Classification of Invasive Devices in Belgium, 2007; Figure 64: Flowchart for Classification of Active Devices in Belgium, 2007; Figure 65: Flowchart for Classification of Active Devices in Belgium, 2007; Figure 66: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Belgium, 2007; Figure 67: Conformity Assessment of Class-I Medical Devices in Belgium, 2007; Figure 68: Conformity Assessment of Class-IIa Medical Devices in Belgium, 2007; Figure 69: Conformity Assessment of Class-IIb Medical Devices in Belgium, 2007; Figure 70: Conformity Assessment of Class-III Medical Devices in Belgium, 2007; Figure 71: Global Markets Direct Methodology

Abstract

Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Belgium drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Belgium

Scope

The report provides drug delivery devices information broken down into detailed categories and segments in Belgium.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in Belgium.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Table of Contents

Abstract